MAS
AMED

Meeder Advisory Services’s Amedisys AMED Stock Holding History

Meeder Advisory Services’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,039
Closed -$496K – 625
2025
Q2 		$496K Buy
5,039
+2,000
+66% +$189K 0.03% 376
2025
Q1 		$282K Buy
3,039
+688
+29% +$63.4K 0.02% 471
2024
Q4 		$213K Buy
+2,351
New +$216K 0.01% 524

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Meeder Advisory Services's AMED Position: Q3 2025 in Review

Meeder Advisory Services sold out of Amedisys (AMED) in Q3 2025, closing a stake of 5,039 shares — an estimated $496K sold.

Meeder Advisory Services first reported a position in AMED in Q4 2024 and held it in 3 quarters. The position peaked at $496K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Meeder Advisory Services reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Meeder Advisory Services sold 5,039 Amedisys shares in Q3 2025, an estimated $496K.
  • Meeder Advisory Services first reported a position in Amedisys in Q4 2024 and held it in 3 quarters.
  • Meeder Advisory Services's Amedisys position peaked at $496K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Meeder Advisory Services's 13F filing for Q3 2025, filed 24 Oct 2025.